# US 2014/0194963 A1 · Polyisobutylene urethane, urea and urethane/urea copolymers and medical leads containing the same > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 2014/0194963 A1 - Document ID: US20140194963A1 - Status: Published application - Kind: A1 - Application number: 14/163,281 - Filed: 2014-01-24 - Published: 2014-07-10 - Earliest claimed: 2009-09-02 - Assignees: Cardiac Pacemakers, Inc. - Applicants: Cardiac Pacemakers, Inc. - Inventors: Shrojalkmar Desai; Mark W. Boden; Stephen E. DeRoche; Arthur J. Foster; G. Shantanu Reddy - Web page: https://patentgrep.com/patent/US20140194963A1 ## CPC - A61N 1/056: {Transvascular endocardial electrode systems} - A61L 31/06: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)} - A61N 1/05: for implantation or insertion into the body, e.g. heart electrode (A61N1/06 takes precedence) - C08G 18/4854: {Polyethers containing oxyalkylene groups having four carbon atoms in the alkylene group} - C08G 18/698: {Mixtures with compounds of group C08G18/40} - Y10T 156/10: Methods of surface bonding and/or assembly therefor - Y10T 428/31855: Of addition polymer from unsaturated monomers - Y10T 428/31938: Polymer of monoethylenically unsaturated hydrocarbon - A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B) - A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K) - C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS - Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION ## Abstract The present invention provides medical devices that contain polyisobutylene urethane copolymers, polyisobutylene urea copolymers and polyisobutylene urethane/urea copolymers. More particularly, the present invention provides medical leads that contain such copolymer. ## Claims ### Claim 1 An implantable medical lead comprising: a first elongated polymeric component disposed over at least one electrical conductor, wherein the first elongated polymeric component comprises: a main lead portion ranging from about 5 cm to about 125 cm in length and having a Shore hardness; and a distal tip portion positioned distal to the main lead portion of the first elongated polymeric component, the distal tip portion ranging from about 1 cm to about 12 cm in length and having a lower Shore hardness than the main lead portion of the first elongated component, wherein at least a portion of the first elongated polymeric component comprises a polyisobutylene-based urethane copolymer having a weight ratio of soft segments to hard segments ranging from 90:10 to 50:50; and a second elongated polymeric component disposed over at least a portion of the first elongated polymeric component, wherein the second elongated polymeric component comprises: a main lead portion ranging from about 5 cm to about 125 cm in length and having a Shore hardness; and a distal tip portion positioned distal to the main lead portion of the second elongated polymeric component, the distal tip portion ranging from about 1 cm to about 12 cm in length and having a lower Shore hardness than the main lead portion of the second elongated polymeric component, wherein at least a portion of the second elongated polymeric component comprises a polyisobutylene-based urethane copolymer having a weight ratio of soft segments to hard segments ranging from 90:10 to 50:50. ### Claim 2 (depends on 1) The implantable medical lead of claim 1, wherein the first elongated polymeric component is fused to the second elongated polymeric component at at least one location. ### Claim 3 (depends on 1) The implantable medical lead of claim 1, wherein the first elongated polymeric component and the second elongated polymeric component are fused to form a ring-shaped thermally fused region between at least a portion of the first elongated polymeric component and the second elongated polymeric component. ### Claim 4 (depends on 1) The implantable medical lead of claim 1, wherein the main lead portion of the first elongated polymeric component has a Shore hardness ranging from about 75A to about 100A and the distal tip portion of the first elongated polymeric component has a Shore hardness ranging from about 30A to about 80A. ### Claim 5 (depends on 4) The implantable medical lead of claim 4, wherein the main lead portion of the second elongated polymeric component has a Shore hardness ranging from about 75A to about 100A and the distal tip portion of the second elongated polymeric component has a Shore hardness ranging from about 30A to about 80A. ### Claim 6 (depends on 1) The implantable medical lead of claim 1, wherein the soft segments comprise polyisobutylene and the hard segments comprise a diisocyanate residue. ### Claim 7 (depends on 6) The implantable medical lead of claim 6, wherein the soft segments further comprise residue of a polytetramethylene oxide diol. ### Claim 8 (depends on 1) The implantable medical lead of claim 1, wherein the first elongated polymeric component comprises a proximal portion that is positioned proximal to the main lead portion of the first elongated component, the proximal portion of the first elongated polymeric component ranging from about 10 to about 15 cm in length and having a Shore hardness ranging from about 80A to about 98A. ### Claim 9 (depends on 8) The implantable medical lead of claim 8, wherein the second elongated polymeric component comprises a proximal portion that is positioned proximal to the main lead portion of the second elongated polymeric component, the proximal portion of the second elongated polymeric component ranging from about 10 to about 15 cm in length and having a Shore hardness ranging from about 80A to about 98A. ### Claim 10 (depends on 9) The implantable medical lead of claim 9, wherein the first elongated polymeric component further comprises an additional portion positioned between the proximal portion and the main lead portion of the first elongated polymeric component, the additional portion ranging from about 7.5 to about 12 cm in length and having a Shore hardness ranging from about 70A to 85A. ### Claim 11 A method of manufacturing an implantable medical lead comprising: forming an elongated polymeric component comprising an inner elongated polymeric component and an outer elongated polymeric component disposed over at least a portion of the inner elongated polymeric component, the inner elongated polymeric component is formed from a first polyisobutylene-based urethane copolymer comprising soft segments and hard segments and having a weight of soft segments to hard segments ranging from 90:10 to 50:50, the inner elongated polymeric component comprises a main lead body portion ranging from about 5 cm to about 125 cm in length and having a Shore hardness and a distal tip portion positioned distal to the main lead body portion of the inner elongated polymeric component, the distal tip portion of the inner elongated polymeric component ranging from about 1 cm to about 12 cm in length and having a lower Shore hardness than the main lead body portion of the inner elongated polymer component ranging from about 30A to about 80A, the outer elongated polymeric component comprises a main lead body portion ranging from about 5 cm to about 125 cm in length and having a Shore hardness and a distal tip portion of the outer elongated polymeric component positioned distal to the main lead body portion of the outer elongated polymeric component, the distal tip portion ranging from about 1 cm to about 12 cm in length and having a lower Shore hardness that the main lead body portion of the outer elongated polymeric component ranging from about 30A to about 80A; associating at least the main lead body portion of the inner elongated polymer component with a conductor and an electrode connected to the conductor. ### Claim 12 (depends on 11) The method claim 11, wherein the outer elongated polymeric component is formed from a second polyisobutylene-based urethane copolymer comprising soft segments and hard segments and having a weight of soft segments to hard segments ranging from 90:10 to 50:50. ### Claim 13 (depends on 11) The method of claim 11, wherein forming the elongated polymeric component comprises co-extruding the inner elongated polymeric component and the outer elongated polymeric component. ### Claim 14 (depends on 11) The method of claim 11, wherein forming the elongated polymeric component comprises extruding the outer elongated polymeric component over the inner elongated polymeric component. ### Claim 15 (depends on 11) The method of claim 11, wherein forming the elongated polymeric component comprises forming the inner elongated polymeric component, forming the outer elongated polymeric component and positioning the formed outer elongate polymeric component over the formed inner elongated polymeric component. ### Claim 16 (depends on 11) The method of claim 11, wherein forming the elongated polymeric component comprises fusing at least a portion of the inner elongated polymeric component to at least a portion of the outer elongated polymeric component. ### Claim 17 (depends on 11) The method of claim 11, wherein forming the elongated polymeric component comprises forming a ring-shaped thermally fused region between at least a portion of the inner elongated polymeric component and at least a portion of the outer elongated polymeric component. ### Claim 18 (depends on 11) The method of claim 11, wherein the main lead body portion of the inner elongated polymeric component comprises a first portion and a second portion that is coaxial with the first portion of the inner elongated polymeric component, wherein at least one of the first and second portions of the inner elongated polymeric component is formed from the first polyisobutylene-based urethane copolymer. ### Claim 19 (depends on 18) The method of claim 18, wherein main lead body portion of the outer elongated polymeric component comprises a first portion and a second portion that is coaxial with the first portion of the outer elongated polymeric component, wherein at least one of the first and second portions of the outer elongated polymeric component is formed from the second polyisobutylene-based urethane copolymer.